Details
Stereochemistry | RACEMIC |
Molecular Formula | C24H29FN2O4 |
Molecular Weight | 428.4965 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC=C1OCCCN2CCC(CC2)C3=NOC4=CC(F)=CC=C34)C(C)O
InChI
InChIKey=SBKZGLWZGZQVHA-UHFFFAOYSA-N
InChI=1S/C24H29FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-17,28H,3,8-13H2,1-2H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11999907Curator's Comment: The description was created based on several sources, including
https://goo.gl/ntDHH8 | https://www.ncbi.nlm.nih.gov/pubmed/23618742 | https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022192s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/7707315
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11999907
Curator's Comment: The description was created based on several sources, including
https://goo.gl/ntDHH8 | https://www.ncbi.nlm.nih.gov/pubmed/23618742 | https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022192s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/7707315
P-88-8991 (Hydroxy Iloperidone, 4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl] propoxy]- 3-methoxy-methylbenzenemethanol) is the major active metabolite of Iloperidone an atypical antipsychotic that used for the acute treatment of schizophrenia in adults. Metabolic reduction of Iloperidone carbonyl group leads to P-88-8991 in rats, dogs, and humans. The receptor affinity profile of P-88-8991 is comparable to that of iloperidone: this metabolite binds to the serotonin 5-HT2A receptors, adrenergic alpha1 and alpha2C receptors, and D2A receptors and with lower affinity to other monoamine (dopamine, serotonin, and histamine H1 ) receptors. The comparable receptor binding profile of P-88-8991 indicates that it is likely to contribute to the clinical profile of iloperidone. Preclinical experiments, such as the mouse apomorphine climbing test, the rat self-stimulation, and the pole climb avoidance task, indicate antipsychotic activity of P88-8991 and confirm that this metabolite crosses the blood–brain barrier
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL214 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11999907 |
6.37 null [pKi] | ||
Target ID: CHEMBL224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11999907 |
9.56 null [pKi] | ||
Target ID: CHEMBL225 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11999907 |
7.16 null [pKi] | ||
Target ID: CHEMBL217 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11999907 |
7.8 null [pKi] | ||
Target ID: CHEMBL314 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11999907 |
7.79 null [pKi] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.google.com/patents/US5776963 |
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7707315
Male Wistar rats (150-250 g) were dosed ip with compound 57 at 2-20mk/kg
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11999907
Membranes from Chinese hamster ovary CHO cells expressing human recombinant 5-HT2A receptors were used for activity evaluation. The binding studies were performed in 96-well plates (Dynatech, Billinghurst, UK) in a total volume of 250 mkl, consisting of the radioligand [3H] Ketanserin (0.5 nM), drug (P-88-8991) and CHO membrane preparation diluted in 50 mM Tris buffer with pH 7.7. The plates were incubated for 15 min at 22 C Nonspecific binding was determined in the presence of ketanserin (10 mkM). Reactions were terminated by flash filtration and inverse transfer to 96-well filter plates [Perkin Elmer/Packard Bioscience, Mericlen, CT, USA 96-well cell harvester, filter plates GFC, coated with plasminogen activator inhibitor (PAI) as necessary]. The plates were dried for 30 min at 56 C and sealed at the bottom with an adhesive sheet (Topseal; Perkin Elmer/Packard Bioscience). Subsequently, 50 mkl of scintillation fluid (Microscint-20; Perkin Elmer/Packard Bioscience) was added to each well, the plates sealed on top and the radioactivity counted in a 96-well plate counter (Topcount; Perkin Elmer/Packard Bioscience).
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9823904
Created by
admin on Sat Dec 16 11:12:35 GMT 2023 , Edited by admin on Sat Dec 16 11:12:35 GMT 2023
|
PRIMARY | |||
|
133454-55-4
Created by
admin on Sat Dec 16 11:12:35 GMT 2023 , Edited by admin on Sat Dec 16 11:12:35 GMT 2023
|
PRIMARY | |||
|
DTXSID10431361
Created by
admin on Sat Dec 16 11:12:35 GMT 2023 , Edited by admin on Sat Dec 16 11:12:35 GMT 2023
|
PRIMARY | |||
|
ARO6P38EJS
Created by
admin on Sat Dec 16 11:12:35 GMT 2023 , Edited by admin on Sat Dec 16 11:12:35 GMT 2023
|
PRIMARY |
PARENT (METABOLITE ACTIVE)
SUBSTANCE RECORD